Animal Cloning: A Risk Assessment
Appearance
This work is incomplete. If you'd like to help expand it, see the help pages and the style guide, or leave a comment on the talk page. |
![]() | A scan-backed, verifiable version of this work can be edited at Index:Animal Cloning; A Risk Assessment (2008).pdf. If you would like to help, please see Help:Match and split and Help:Proofread. |
Animal Cloning:
A Risk Assessment
Center for Veterinary Medicine
U. S. Food and Drug Administration
Department of Health and Human Services
7500 Standish Place
Rockville, MD 20855
1/8/2008
![]() |
|
![]() |
Table of Contents
Preface | i | |
Chapter I: Executive Summary | 3 | |
A. | Overview | 3 |
B. | Technology Overview (Chapter II) | 4 |
C. | Risk Assessment Methodology (Chapter III) | 5 |
D. | The Implications of Epigenetic Reprogramming for Clones and their Progeny (Chapter IV) | 8 |
E. | Risks to Animals Involved in Cloning (Chapter V) | 9 |
F. | Food Consumption Risks (Chapter VI) | 11 |
1. Two-Pronged Approach to Identifying and Characterizing Food Consumption Risks | 11 | |
2. Conclusions Regarding Potential Food Consumption Risks | 11 | |
a. Cattle Clones | 11 | |
b. Swine Clones | 13 | |
c. Sheep Clones | 14 | |
d. Goat Clones | 14 | |
e. Clone Progeny | 14 | |
G. | Concluding Statements (Chapter VII) | 15 |
Chapter II: Technology Overview: Somatic Cell Nuclear Transfer and Other Assisted Reproductive Technologies | 19 | |
A. | What is Cloning? | 20 |
B. | Continuum of Reproductive Technologies | 21 |
1. Natural Service | 21 | |
2. Artificial Insemination and Synchronized Estrus | 22 | |
3. Embryo Transfer | 25 | |
4. In vitro Fertilization | 26 | |
5. Embryo splitting | 27 | |
6. Blastomere Nuclear Transfer | 28 | |
7. Somatic Cell Nuclear Transfer (SCNT) | 29 | |
a. Donor cell | 30 | |
b. Oöcyte | 31 | |
c. Fusion | 31 | |
d. Transfer to recipient | 32 | |
C. | Critical Biological Events in SCNT | 33 |
D. | Outcomes Observed in ARTs | 35 |
E. | Future of Reproductive Technologies in Modern Agricultural Practice | 36 |
Chapter III: Developing the Risk Assessment Methodology | 41 | |
A. | Charge | 41 |
B. | General Discussion of Risk/Safety Analyses | 41 |
1. Risk and Safety | 41 | |
2. Risk Assessment vs. Risk Management | 42 | |
C. | Risk/Safety Assessment of Cloning | 42 |
D. | Transgenic Animal Clones | 44 |
E. | Methodology Development | 45 |
1. Hazard Characterization | 46 | |
2. Potential Risks | 47 | |
3. Proposed Approaches | 48 | |
a. Animal Health Risks | 48 | |
b. Food Consumption Risks | 49 | |
F. | Two-Pronged Approach to Assessing Food Consumption Risks | 50 |
1. Critical Biological Systems Approach | 51 | |
a. Overview | 51 | |
b. Evaluation Nodes | 52 | |
G. | The Weight of Evidence Approach | 54 |
H. | Limitations of the Risk Assessment | 55 |
Chapter IV: Epigenetic Reprogramming: Implications for Clones and their Progeny | 59 | |
A. | Overview of Epigenetic Reprogramming in Early Embryonic Development | 61 |
1. Preimplantation Reprogramming | 63 | |
a. Fusion and Cleavage | 63 | |
b. Demethylation and Remethylation in Early Embryos | 66 | |
c. Epigenetic Reprogramming in Later Development | 70 | |
d. Studies of Gene Expression and Development in Clones and Animals Produced by Other ARTs | 73 | |
e. Studies of Technical Contributions to Epigenetic Variability in Clones and Other ARTs | 78 | |
2. Gametogenic Reprogramming | 79 | |
3. Mitochondrial Heteroplasmy | 81 | |
4. Conclusions from Studies of Epigenetic Reprogramming | 82 | |
B. | Phenotypic Evidence for Gametogenic Reprogramming | 83 |
1. Phenotypic Anomalies Observed in Mouse Clones | 83 | |
a. Utility of Mouse Model | 83 | |
b. Pregnancy (Developmental Node 1) | 84 | |
c. Perinatal Period (Developmental Node 2) | 86 | |
d. Juvenile Period to Reproductive Maturity (Developmental Nodes 3 and 4) | 86 | |
e. Maturity and Aging (Developmental Node 5) | 88 | |
2. Conclusions from Phenotypic Studies of Gametogenic Reprogramming in Mouse Clones and their Progeny for Reprogramming in Domestic Livestock Clones and their Progeny | 90 | |
C. | Implications of Epigenetic Reprogramming for Animal Health and Food Consumption Risks | 91 |
Chapter V: Animal Health Risks | 95 | |
A. | Potential Hazards and Risks to Animals Involved in Cloning | 95 |
B. | The Critical Biological Systems Approach to the Analysis of Clone Animal Health: Cattle, Swine, Sheep, and Goats | 96 |
1. Pregnancy and Parturition (Developmental Node 1) | 96 | |
2. Perinatal Period (Developmental Node 2) | 98 | |
3. Juvenile Developmental Node (Developmental Node 3) | 99 | |
4. Reproductive Development and Function Node (Developmental Node 4) | 100 | |
5. Post-Pubertal Maturation and Aging (Developmental Node 5) | 101 | |
a. Telomere Length as an Indicator of Aging | 101 | |
C. | Data on Animal Health by Species | 105 |
1. Cattle | 105 | |
a. Developmental Node 1: Pregnancy and Parturition | 109 | |
b. Developmental Node 2: Perinatal Period | 123 | |
c. Developmental Node 3: Juvenile Development | 135 | |
d. Developmental Node 4: Reproductive Development and Function | 145 | |
e. Developmental Node 5: Post-Pubertal Maturation and Aging | 150 | |
f. Progeny of Bovine Clones | 153 | |
g. Summary for Health of Bovine Clones and Their Progeny | 156 | |
2. Swine | 157 | |
a. Developmental Node 1: Pregnancy and Parturition | 158 | |
b. Developmental Node 2: Perinatal Period | 159 | |
c. Developmental Node 3: Juvenile Development | 163 | |
d. Developmental Node 4: Reproductive Development and Function | 165 | |
e. Developmental Node 5: Post-Pubertal Maturation and Aging | 166 | |
f. Progeny of Swine Clones | 166 | |
g. Summary for Health of Swine Clones and Their Progeny | 167 | |
3. Sheep | 168 | |
a. Developmental Node 1: Pregnancy and Parturition | 169 | |
b. Developmental Node 2: Perinatal Period | 172 | |
c. Developmental Node 3: Juvenile Development | 174 | |
d. Developmental Node 4: Reproductive Development and Function | 175 | |
e. Developmental Node 5: Post-Pubertal Maturation and Aging | 175 | |
f. Progeny of Sheep Clones | 176 | |
g. Summary for Health of Sheep Clones | 176 | |
4. Goats | 176 | |
a. Developmental Node 1: Pregnancy and Parturition | 177 | |
b. Developmental Node 2: Perinatal Period | 178 | |
c. Developmental Node 3: Juvenile Development | 179 | |
d. Development Node 4: Reproductive Development and Function | 180 | |
e. Developmental Node 5: Post-Pubertal Maturation and Aging | 180 | |
f. Progeny of Goat Clones | 180 | |
g. Summary for Health of Goat Clones | 181 | |
D. | Conclusions | 181 |
Chapter VI: Food Consumption Risks | 187 | |
A. | Potential Hazards and Food Consumption Risks Associated with Food Products from Animal Clones and their Progeny | 187 |
1. Assumptions | 187 | |
2. Critical Biological Systems Approach to Clones of Cattle, Swine, Sheep, and Goats | 188 | |
a. Bovine Clones | 188 | |
b. Swine Clones | 243 | |
c. Sheep Clones | 260 | |
d. Goat Clones | 264 | |
3. Compositional Analysis Method | 268 | |
a. Overview | 268 | |
b. Nutritional Risk | 269 | |
c. Characterization of Milk from Cow Clones | 278 | |
d. Characterization of Meat from Clones and Their Progeny | 288 | |
B. | Drawing Conclusions Regarding Risks Associated with Consumption of Food Products from Animal Clones | 309 |
1. Approaches for Decreasing Uncertainties | 309 | |
2. Bounding the Risk Space | 310 | |
3. Developing Conclusions Regarding Food Consumption Risks | 310 | |
4. Weight of Evidence Conclusions Regarding Food Consumption Risks for Clones and their Progeny | 312 | |
a. Cattle Clones | 312 | |
b. Swine Clones | 316 | |
c. Sheep Clones | 317 | |
d. Goat Clones | 318 | |
e. Clone Progeny | 319 | |
5. Summary of Risk Hypotheses | 319 | |
a. Additional Issues | 320 | |
6. How Much (Information) Is Enough? | 323 | |
Chapter VII Summary and Conclusions | 327 | |
A. | Methodology | 327 |
B. | Conclusions Regarding Risks to Animal Health | 328 |
C. | Conclusions Regarding Food Consumption Risks | 329 |
D. | Conclusions Regarding Food Consumption Risks from Clone Progeny | 330 |
E. | Weight of Evidence Evaluations | 330 |
Glossary | 333 | |
References | 349 | |
Appendices | ||
Appendix A: Risk and Safety Assessment Primer for Animal Cloning | 425 | |
A. | How has Risk Assessment Evolved? | 425 |
B. | Thinking About Risk | 426 |
C. | How Do We Think About Safety? | 428 |
Appendix B: Overall Reproductive Efficiency and Health Statistics for US Animal Agriculture | 431 | |
A. | Dairy cattle | 431 |
B. | Beef Cattle | 433 |
C. | Swine | 436 |
D. | Sheep | 437 |
D. | Goats | 439 |
Appendix C: Comparisons of Outcomes Among Assisted Reproductive Technologies (ARTs) | 443 | |
A. | Successes and Failures of AI, IVP, and ET | 449 |
B. | Outcomes for BNT, Fetal- and Adult-Cell SCNT | 453 |
C. | Conclusions regarding outcomes for ARTs | 454 |
Appendix D Transgenic Clones | 457 | |
A. | Issues | 457 |
B. | Cattle | 458 |
C. | Swine | 460 |
D. | Sheep | 462 |
E. | Goats | 463 |
F. | Conclusions Regarding Transgenic Clones | 466 |
Appendix E: The Cyagra Dataset | 471 | |
A. | Response to CVM Data Requests | 471 |
B. | Cyagra Dataset | 472 |
1. Description of Clones | 474 | |
2. Evaluations Performed | 476 | |
3. CVM's Analysis of Cyagra Data: Method | 477 | |
4. CVM's Analysis of Cyagra Data: Results | 479 | |
a. Comprehensive Veterinary Examinations | 479 | |
b. Conclusions from Veterinary Examinations | 480 | |
c. Laboratory Values: Selection of Most Appropriate Comparator | 481 | |
d. Conclusions Regarding Clone and Comparator Population Cohorts in Aggregate | 482 | |
e. Animal and Analyte Specific Analyses | 484 | |
f. Animals with Measurements at Different Developmental Nodes | 487 | |
5. Charts and Tables | 500 | |
Cyagra Data Chart Interpretations | 501 | |
Cyagra Raw Data | 523 | |
Appendix F: The ViaGen Dataset | 571 | |
A. | Background | 571 |
B. | Experimental Design | 571 |
1. Study 1: Clones vs. Comparators | 573 | |
a. Animal Health, Hematology, Clinical Chemistry, and Urinalysis | 574 | |
b. Boar Semen Evaluation | 574 | |
c. Farrowing Rate | 574 | |
2. Study 2: Progeny of Clone Boars vs. Progeny of Conventional Boars | 575 | |
a. Statistical Analysis | 575 | |
b. Specific Methods for the Analysis of Animal Health, Hematology, Clinical Chemistry, and Urinalysis Data | 578 | |
c. Meat Composition, Carcass Characteristics, and Meat Quality Assessments for Clones, Comparators, and Progeny | 578 | |
C. | Results | 579 |
1. Study 1 | 579 | |
a. Survival | 579 | |
b. Animal Health, Growth, Blood Clinical Chemistry, Hematology, and Urinalysis | 580 | |
c. Carcass Characteristics | 588 | |
d. Meat Composition Analysis for Clones and Comparators | 589 | |
e. Semen and Breeding Evaluation | 591 | |
f. Farrowing Rate | 592 | |
2. Study 2: Progeny of Clones vs. Comparators | 594 | |
a. Survival | 594 | |
b. Growth, Hematology, Clinical Chemistry, and Urinalysis | 600 | |
c. Carcass Characteristics | 608 | |
d. Meat Composition from the Progeny of Clones and Comparators | 609 | |
D. | Conclusions from the ViaGen Dataset | 614 |
1. Study 1: Clones vs. Comparators | 614 | |
a. Animal Health | 614 | |
b. Food Safety | 615 | |
2. Progeny of Clone Boars vs. Progeny of Comparator Boars | 615 | |
a. Animal Health | 615 | |
b. Food Safety | 616 | |
E. | Addendum | 617 |
ViaGen Data Chart Interpretations | 621 | |
ViaGen Raw Data | 695 | |
Appendix G: Unpublished Data | 857 | |
A. | Perinatal Development in Cattle Clones (Node 2) | 857 |
B. | Juvenile Development in Cattle Clones (Node 3) | 859 |
C. | Reproductive Development and Function in Cattle Clones (Node 4) | 865 |
D. | Post-pubertal Maturation in Cattle Clones (Node 5) | 867 |
E. | Summary of Cloning Studies at University of Tennessee | 868 |
1. Developmental Node 1: Pregnancy and Parturition | 868 | |
2. Developmental Node 2: Perinatal Period | 869 | |
3. Developmental Node 3: Juvenile Period | 869 | |
4. Developmental Node 4: Reproductive Development and Function | 869 | |
5. Developmental Node 5: .Post-pubertal Maturation and Aging | 870 | |
F. | Perinatal Development in Swine Clones (Node 2) | 870 |
G. | Conclusions for unpublished data | 872 |
Appendix H: The Comprehensive Veterinary Examination | 877 | |
A. | Introduction to the Comprehensive Veterinary Examination | 877 |
B. | The Importance of Species-Specific Standards | 878 |
C. | How a Veterinarian Performs a Comprehensive Veterinary Examination | 878 |
1. Specific Considerations for Neonatal CVEs | 880 | |
2. Specific Considerations for Juvenile CVEs | 881 | |
3. Specific Considerations for Mature Animal CVEs | 881 | |
4. Specific Consideration for Reproductive Stage Examinations | 881 | |
a. Males | 881 | |
b. Females | 882 | |
D. | Interpreting the Comprehensive Veterinary Examination for Animal Clones | 883 |
E. | Parameters Evaluated in the Comprehensive Veterinary Exam for a Risk Assessment | 883 |
Appendix I: Investigation on the Attributes of Cloned Bovine Products | 895 |
This work is in the public domain in the United States because it is a work of the United States federal government (see 17 U.S.C. 105).
Public domainPublic domainfalsefalse